These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30503939)

  • 1. Ligand design for somatostatin receptor isoforms 4 and 5.
    Negi A; Zhou J; Sweeney S; Murphy PV
    Eur J Med Chem; 2019 Feb; 163():148-159. PubMed ID: 30503939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-targeting protein-protein interaction inhibitors: Evolution of macrocyclic ligands with embedded carbohydrates (MECs) to improve selectivity.
    Negi A; Reilly CO; Jarikote DV; Zhou J; Murphy PV
    Eur J Med Chem; 2019 Aug; 176():292-309. PubMed ID: 31112891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformationally homogeneous heterocyclic pseudotetrapeptides as three-dimensional scaffolds for rational drug design: receptor-selective somatostatin analogues.
    Beierle JM; Horne WS; van Maarseveen JH; Waser B; Reubi JC; Ghadiri MR
    Angew Chem Int Ed Engl; 2009; 48(26):4725-9. PubMed ID: 19266506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of potent cyclic hexapeptide NK-1 antagonists. Use of a minilibrary in transforming a peptidal somatostatin receptor ligand into an NK-1 receptor ligand via a polyvalent peptidomimetic.
    Hirschmann R; Yao W; Cascieri MA; Strader CD; Maechler L; Cichy-Knight MA; Hynes J; van Rijn RD; Sprengeler PA; Smith AB
    J Med Chem; 1996 Jun; 39(13):2441-8. PubMed ID: 8691440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of somatostatin mimetics based on the 1-deoxymannojirimycin scaffold.
    Gouin SG; Murphy PV
    J Org Chem; 2005 Oct; 70(21):8527-32. PubMed ID: 16209603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
    Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
    J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in the discovery of selective, non-peptide ligands of somatostatin receptors.
    Wolkenberg SE; Thut CJ
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):446-57. PubMed ID: 18600562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combinatorial approach toward the discovery of non-peptide, subtype-selective somatostatin receptor ligands.
    Berk SC; Rohrer SP; Degrado SJ; Birzin ET; Mosley RT; Hutchins SM; Pasternak A; Schaeffer JM; Underwood DJ; Chapman KT
    J Comb Chem; 1999; 1(5):388-96. PubMed ID: 10748735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin Receptor Antagonists for Imaging and Therapy.
    Fani M; Nicolas GP; Wild D
    J Nucl Med; 2017 Sep; 58(Suppl 2):61S-66S. PubMed ID: 28864614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling suggests conformational scaffolds specifically targeting five subtypes of somatostatin receptors.
    Nikiforovich GV; Marshall GR; Achilefu S
    Chem Biol Drug Des; 2007 Mar; 69(3):163-9. PubMed ID: 17441902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chroman-4-one and chromone based somatostatin β-turn mimetics.
    Fridén-Saxin M; Seifert T; Malo M; da Silva Andersson K; Pemberton N; Dyrager C; Friberg A; Dahlén K; Wallén EA; Grøtli M; Luthman K
    Eur J Med Chem; 2016 May; 114():59-64. PubMed ID: 26974375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor subtype-5 mediates inhibition of peptide YY secretion from rat intestinal cultures.
    Chisholm C; Greenberg GR
    Am J Physiol Gastrointest Liver Physiol; 2000 Nov; 279(5):G983-9. PubMed ID: 11052995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of somatostatin mimetics based on 1-deoxynojirimycin.
    Chagnault V; Lalot J; Murphy PV
    ChemMedChem; 2008 Jul; 3(7):1071-6. PubMed ID: 18418832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beta-D-glucose scaffold as a beta-turn mimetic.
    Hirschmann RF; Nicolaou KC; Angeles AR; Chen JS; Smith AB
    Acc Chem Res; 2009 Oct; 42(10):1511-20. PubMed ID: 19624154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of ANP secretion by somatostatin through somatostatin receptor type 2.
    Gao S; Oh YB; Shah A; Park WH; Kim SH
    Peptides; 2011 Jun; 32(6):1179-86. PubMed ID: 21539874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies.
    Pisarek H; Pawlikowski M; Kunert-Radek J; Radek M
    Endokrynol Pol; 2009; 60(4):240-51. PubMed ID: 19753537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol: A minimal scaffold for non-peptide peptidomimetics of the i + 1 and i + 2 positions of the beta-turn of somatostatin.
    Mowery BP; Prasad V; Kenesky CS; Angeles AR; Taylor LL; Feng JJ; Chen WL; Lin A; Cheng FC; Smith AB; Hirschmann R
    Org Lett; 2006 Sep; 8(20):4397-400. PubMed ID: 16986909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders.
    Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F
    J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20.
    Demchyshyn LL; Srikant CB; Sunahara RK; Kent G; Seeman P; Van Tol HH; Panetta R; Patel YC; Niznik HB
    Mol Pharmacol; 1993 Jun; 43(6):894-901. PubMed ID: 8100352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predicted ensemble of low-energy conformations of human somatostatin receptor subtype 5 and the binding of antagonists.
    Dong SS; Abrol R; Goddard WA
    ChemMedChem; 2015 Apr; 10(4):650-61. PubMed ID: 25772628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.